Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services. The ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to ...

Samsung Biologics and Ligachem Biosciences will expand their collaboration on projects to develop antibody-drug conjucates ...

According to the Korea Exchange on the 8th, as of 9:22 a.m., Samsung Biologics was trading at 1 million and 1,000 won, up ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, will attend the upcoming conference set to run ...

Samsung Biologics, a global contract development and manufacturing organization (CDMO), has extended its collaboration with ...

Shares rose more than 1 percent Wednesday, driven by advances in top-cap Samsung Electronics and other tech shares.

Samsung Biologics was recognized for its dedication to embed sustainable business practices across its operations, particularly robust environmental efforts, including progress toward achieving ...

Lotte Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO) established in 2022, is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...